Metraipolis › archive › dc_69b6cd9d47df

Metabolic Benefits vs. Cardiovascular Uncertainty: A Critical Review of GLP-1 Receptor Agonists in Type 1 Diabetes — Europe PMC PMID:42123472

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42123472
DOI
10.3390/ijms27093882
License (as archived)
solo-consultazione
Archived
2026-11-03T03:16:27.198Z
SHA-256 of the archived text
99bdbdb3e1d9d1ed5c4fb32cf8c5cc2c6cfca536522575eeb24b73f20e4e0ae5
Stable URL of this page
https://metraipolis.com/documento/dc_69b6cd9d47df

How to cite

Metabolic Benefits vs. Cardiovascular Uncertainty: A Critical Review of GLP-1 Receptor Agonists in Type 1 Diabetes — Europe PMC PMID:42123472 — Europe PMC (en), https://europepmc.org/article/MED/42123472 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_69b6cd9d47df (Metraipolis archive dc_69b6cd9d47df, sha256 99bdbdb3e1d9d1ed5c4fb32cf8c5cc2c6cfca536522575eeb24b73f20e4e0ae5)
BibTeX
@misc{dc69b6cd9d47df,
  title = {Metabolic Benefits vs. Cardiovascular Uncertainty: A Critical Review of GLP-1 Receptor Agonists in Type 1 Diabetes — Europe PMC PMID:42123472},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42123472},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_69b6cd9d47df; sha256 99bdbdb3e1d9d1ed5c4fb32cf8c5cc2c6cfca536522575eeb24b73f20e4e0ae5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42123472. Agents can read the archived copy with the MCP tool read_document.